Fri, Jul 17, 2020
In a recent webcast, Kroll examined the impact COVID-19 has had on supply chains and explored some of the challenges medical device manufacturers and supply chains are facing.
Key Discussion Points
Download Webcast Slides
For any questions about the webcast, or to get in touch with an expert about managing and mitigating your medical devices risk, please email us.
Read more compliance news and thought leadership on our Compliance Risk and Diligence article feed.
The Kroll Investigations, Diligence and Compliance team partners with clients to anticipate, detect and manage regulatory and reputational risks associated with global ethics and compliance obligations.
Kroll is trusted by companies worldwide to help establish policies and programs aimed toward preventing fraud and complying with anti-money laundering (AML) and anti-bribery and corruption regulations.
Kroll helps clients navigate the complexities of today’s regulatory environment through a broad suite of anti-money laundering compliance screening and due diligence offers.
Helping clients build resiliency by proactively identifying, assessing, mitigating and monitoring their hidden supply chain risks.